Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05899361

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Led by Dana-Farber Cancer Institute · Updated on 2023-10-24

10

Participants Needed

1

Research Sites

173 weeks

Total Duration

On this page

Sponsors

D

Dana-Farber Cancer Institute

Lead Sponsor

S

Siemens Medical Solutions

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and ultrasound probe imaging will aid in reducing the complexity of both laparoscopic lymphadenectomy and/or organ removal in patients with a confirmed diagnosis of cancer in urologic regions of interest (Bladder, Prostate, Testicular, Kidney, Urethral, and Penis), by resulting in better visualization and more accurate localization of certain areas in the diseased organ or the diseased lymph node, and allowing for improved surgical and patient outcomes, fewer complications and better clinician performance.

CONDITIONS

Official Title

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed written informed consent before any trial-related procedure
  • Age 18 years or older
  • Confirmed or suspected diagnosis of disease in urologic regions with scheduled surgical biopsy
  • Had a CT, PET, or MR scan of acceptable quality at Brigham and Women's Hospital within the past year
  • Scheduled for lymph node dissection or organ removal surgery in bladder, prostate, testicle, ureter, kidney, urethra, penis, or scrotum
  • Scheduled to undergo laparoscopic lymph node dissection and/or urologic organ removal within any OR at Brigham and Women's Hospital
Not Eligible

You will not qualify if you...

  • Severely impaired kidney function with EGFR less than 30 mL/min/body surface area
  • Significant uncontrolled medical condition affecting study compliance or result interpretation
  • History of allergy or contraindication to contrast media
  • Contraindication to general anesthesia
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

Research Team

M

Matthew Mossanen, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here